Indoco Remedies Ltd (NSE:INDOCO)

Q1 2026 Indoco Remedies Ltd Earnings Call Transcript

Jul 24, 2025 / 10:00 AM GMT

Release Date Price: ₹321.8 (+3.42%)

Transcript

Key Points

Positve

Indoco Remedies Ltd (BOM:532612) reported a significant improvement in their OTC business, with a growth of more than 46% over the immediate preceding quarter.
The company has successfully rolled out phase one of its master manufacturing program, resulting in a 26% increase in international business.
European authorities have approved the Goa plant for sterile product supply, indicating successful remediation efforts and compliance with global manufacturing standards.
The company has shown improvement in EBITDA both on a standalone and consolidated basis despite challenges.
Indoco Remedies Ltd (BOM:532612) has seen a 12.5% growth in standalone net revenues compared to the previous quarter.

Negative

The company is still facing challenges with the US FDA warning letter on the Goa plant, with remediation efforts ongoing and expected to complete by December.
There was a decline in revenues from the US business, Europe, and regulated markets compared to the same quarter last year.
Interest costs have increased due to overall exposure to long-term and short-term borrowings.
The domestic formulation business showed flat growth compared to the same quarter last year.
The company is still in the process of achieving full efficiency in its manufacturing plants, with phase two expected to complete by the end of Q2.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INRM.NS - Indoco Remedies Ltd
Q1 2026 Indoco Remedies Ltd Earnings Call
Jul 24, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Indigo Remedies Q1F 526 earnings conference call hosted by Dole Capital Markets Private Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing 0 on your touchstone phone. Please note that this conference has been recorded. I now hand the conference over to Ms. Rashmi Shetty.

Thank you and over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.